Connect
MJA
MJA

Tissue plasminogen activator (tPA) in acute ischaemic stroke: time for collegiate communication and consensus

Med J Aust 2005; 182 (1): .
Published online: 3 January 2005

Christopher R Levi (on behalf of the Australasian Stroke Unit Network, the New South Wales Greater Metropolitan Clinical Taskforce Stroke Initiative, and the Towards A Safer Culture Stroke Expert Working Group)


  • Acute Stroke Services, John Hunter Hospital, Locked Bag No. 1, Hunter Region Mail Centre, NSW 2310. christopher.leviAThunter.health.nsw.gov.au



  • 1. Levi CR, on behalf of the Australasian Stroke Unit Network, the New South Wales Greater Metropolitan Transition Taskforce Stroke Initiative, and the Towards A Safer Culture Stroke Expert Working Group. Tissue plasminogen activator (tPA) in acute ischaemic stroke: time for collegiate communication and consensus. Med J Aust 2004; 180: 634-636. <MJA full text>
  • 2. Mayer SA, Brun N, Broderick J, et al. Recombinant factor VIIa for acute intracerebral haemorrhage. Presented at the 5th World Stroke Congress, 23–26 June 2004, Vancouver, Canada. Stroke 2004; 35 (6).
  • 3. Furlan A, Higashida R, Wechsler L, et al, for the PROACT investigators. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003-2011.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.